Angiotensin Receptor Blocker Associated with a Decreased Risk of Lung Cancer: An Updated Meta-Analysis.

Zexu Wang,Lingyun Wei,Cheng Yin,Wang Li,Bing Wan

Journal of personalized medicine（2023）

引用 1|浏览4

暂无评分

摘要

Compared with ACEIs and CCBs, ARBs significantly reduce the risk of lung cancer, especially in Asian and Mongolian populations. Valsartan has the best effect in reducing the risk of lung cancer in ARB drugs.

查看译文

关键词

Asian,Valsartan,angiotensin receptor blockers (ARB),incidence of lung cancer,risk of lung cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要